Street Insider 3 weeks ago

BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results

BioSante incurred a net loss of approximately $6.4 million or ($0.21) per share for the quarter ended September 30, 2009, compared to a net loss of $6.6 million or ($0.24) per share for the same period in 2008. Full Article at Street Insider

Related Topics:

Related Articles

  1. 2009-11-09 22:44:01 - in April 2009 to delay screening of new subjects for its ongoing LibiGel ® (testosterone gel) Phase III safety study, partially offset by the recognition of acquisition related costs of approximately $1.5 million... Full Article at PR-Inside.com

  2. GTx Inc. reported $3.6 million in third quarter revenue, a slight drop from the $3.8 million the company reported for the second quarter of 2009. GTx reported revenues of $3 million for the third quarter of 2008. Full Article at Memphis Business Journal

  3. BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009. Full Article at News-Medical.net

  4. Caraco Pharmaceutical Laboratories (NYSE Amex: CPD) posted net income of $6.7 million for the second quarter 2010, or 16 cents per diluted share, down slightly from $8.4 million, or 21 cents per diluted share, for the same period in 2009. Full Article at Crain's Detroit Business

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. Reps. Sue Myrick, R-N.C. , center, gestures during a news conference on Capitol Hill in Washington, Wednesday, Nov. 18, 2009, to discuss the new mammogram guidelines.
  2. WASHINGTON - NOVEMBER 13:  U.S. first lady Michelle Obama (L) shares a moment with Fran Garfinkle (R) of Bethesda, Maryland, who was diagnosed with breast cancer last year and currently receiving Medicare and Social Security, during an East Room event November 13, 2009 at the White House in Washi...
  3. NEW YORK - NOVEMBER 05: Editor-in-Chief of Allure Linda Wells and President of Gucci America Daniella Vitale attend the 14th annual National Breast Cancer Coalition Fund's New York Gala at Cipriani 42nd Street on November 5, 2009 in New York City.
  4. GARDEN GROVE, CA - NOVEMBER 4:  Former Hewlett-Packard chief executive officer Carly Fiorina announces to the media her candidacy for U.S. Senate at Earth Friendly Products on November 4, 2009 in Garden Grove, California.
  5. NEW YORK - OCTOBER 28:  Actress Elizabeth Hurley attends the Humanitarian Award ceremony hosted by The Breast Cancer Research Foundation (BCRF) at The Waldorf=Astoria on October 28, 2009 in New York City.
  6. LONDON, ENGLAND - OCTOBER 28:  Sheridan Smith and the cast of Legally Blonde take a break from rehearsals of the musical to support 'Wear It Pink' on October 28, 2009 in London, England.
  7. "Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM) spine sealant, the first product approved by the FDA for intra-operative sealing of the dural membrane during spine procedures."
  8. WASHINGTON - JUNE 12:  University of Florida's Emerging Pathogens Institute Director Glenn Morris testifies before the House Subcommittee on Oversight and Investigations June 12, 2008 in Washington, DC.
  9. WASHINGTON - APRIL 22:  Commissioner of the Food and Drug Administration Andrew von Eschenbach testifies during a hearing before the Subcommittee on Oversight and Investigations of the House Energy & Commerce Committee April 22, 2008 on Capitol Hill in Washington, DC.

Cast of Characters